These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Lifestyle changes in women with polycystic ovary syndrome. Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Cochrane Database Syst Rev; 2011 Jul 06; (7):CD007506. PubMed ID: 21735412 [Abstract] [Full Text] [Related]
9. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis. Wang A, Mo T, Li Q, Shen C, Liu M. Endocrine; 2019 May 06; 64(2):220-232. PubMed ID: 30911997 [Abstract] [Full Text] [Related]
10. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD003053. PubMed ID: 19821299 [Abstract] [Full Text] [Related]
15. Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Lepine S, Jo J, Metwally M, Cheong YC. Cochrane Database Syst Rev; 2017 Nov 10; 11(11):CD009526. PubMed ID: 29125183 [Abstract] [Full Text] [Related]
16. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Misso ML, Costello MF, Garrubba M, Wong J, Hart R, Rombauts L, Melder AM, Norman RJ, Teede HJ. Hum Reprod Update; 2013 Nov 10; 19(1):2-11. PubMed ID: 22956412 [Abstract] [Full Text] [Related]
18. Endocrine and metabolic characteristics in polycystic ovary syndrome. Glintborg D. Dan Med J; 2016 Apr 10; 63(4):. PubMed ID: 27034186 [Abstract] [Full Text] [Related]